Robert Wasserman
Stock Analyst at Benchmark
(1.68)
# 1437
Out of 5,240 analysts
115
Total ratings
53.73%
Success rate
14.14%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Ligand Pharmaceutica... | Reiterates: Buy | 135 135 | 108.66 | 24.24% | 10 | Dec 23, 2024 | |
BioLife Solns | Reiterates: Buy | 30 30 | 26.19 | 14.55% | 6 | Dec 19, 2024 | |
Anebulo Pharmaceutic... | Reiterates: Speculative Buy | 8 8 | 1.6 | 400% | 6 | Nov 19, 2024 | |
OmniAb | Reiterates: Buy | 8 8 | 3.19 | 150.78% | 7 | Nov 14, 2024 | |
Nephros | Reiterates: Speculative Buy | 5 5 | 1.5 | 233.33% | 3 | Nov 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 8 12 | 9.37 | 28.07% | 17 | Nov 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 5 | Nov 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 7 | Nov 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 140 140 | 138.55 | 1.05% | 9 | Oct 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Speculative Buy | 5 3 | 0.45 | 566.67% | 5 | Aug 14, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 95 95 | 74.74 | 27.11% | 5 | Aug 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 60 60 | 53.76 | 11.61% | 7 | Aug 8, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | n/a | n/a | n/a | 3 | Aug 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Speculative Buy | 12 12 | 2.64 | 354.55% | 6 | Jul 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 45 45 | 37.01 | 21.59% | 6 | May 29, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Speculative Buy | 4 | 3.27 | 22.32% | 1 | Mar 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Speculative Buy | 4 | 0.81 | 393.83% | 1 | Mar 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Speculative Buy | 7 | n/a | n/a | 1 | May 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Speculative Buy | 75 | 1.89 | 3868.25% | 2 | Apr 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 3 | Oct 24, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Speculative Buy | 7 | n/a | n/a | 3 | Aug 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 580 | 557.25 | 4.08% | 1 | Jul 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 1386 | n/a | n/a | 1 | Aug 28, 2018 |